Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
FDA
FDA
Page 20 of 35
Health
Another Blood Pressure Medication is Being Recalled
By
Senior Editor
January 8, 2019
Blood Pressure Drug Recall List Expands to Include More Valsartan Tablets
By
Staff Writer
January 3, 2019
Hemp Is Now Federally Legal—But It’ll Be Heavily Regulated
By
Crypto Correspondent
December 21, 2018
Europe Just Banned Allergan Breast Implants. Here’s Why
By
Digital Assets Editor
December 19, 2018
Leadership
A Word of Advice from the FDA: Don’t Eat Glitter
By
Market Analyst
December 14, 2018
Health
FDA Commish Warns Against Eating Raw Cookie Dough With a Dr. Seuss-Inspired Rhyme
By
Tech Reporter
December 11, 2018
Big Tobacco Company Altria Takes Major Stake in Canadian Cannabis Firm Cronos Group
By
Research Team
December 7, 2018
Here’s What the 2018 Farm Bill Has To Do With CBD Legalization
By
Crypto Correspondent
December 5, 2018
FDA Warns Sixth Valsartan Blood Pressure Drug Recalled for Contamination
By
News Correspondent
November 30, 2018
Faulty Medical Devices Prompt FDA Approval-Process Overhaul
By
Staff Writer
November 26, 2018
FDA Recalls Yet Another Blood Pressure Medication, Losartan, Due to Cancer Concerns
By
Research Team
November 13, 2018
Health
Explaining Amarin’s Fishy Stock Slide
By
Crypto Correspondent
November 12, 2018
Popular Birth Control Pills Recalled Over Misprinted Instructions
By
Blockchain Reporter
November 7, 2018
The FDA Is Poised to Approve the First-Ever Postpartum Depression Drug
By
Blockchain Reporter
November 2, 2018
Another Popular Blood Pressure Drug Has Been Recalled by the FDA Over Potential Cancer Risk
By
Trading Desk
November 1, 2018
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Financial Writer
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Contributing Writer
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Blockchain Reporter